PortViewPortView
Black Titan logo

Black Titan (BTTC) Stock Analysis

NASDAQTechnologySoftware - Application

$0.41+0.92%
1-year price historyRange $0.40 – $23.98
52-week range$0.41
$0.40$39.00

What Black Titan does

Black Titan Corporation was formed for the purpose of effecting a merger between Titan Pharmaceuticals Inc. and TalenTec Sdn Bhd. The company offers human capital management solutions and is also focused on strategic expansion into the digital asset and blockchain sectors.

Key metrics

Market cap
$3.14M
P/E (TTM)
-1.29
EPS (TTM)
$-0.32
Beta
1.18
Dividend yield
0.00%
Revenue / share
$2,683.13
50-day avg
$0.72
200-day avg
$1.47
52-week high
$39.00
52-week low
$0.40
CEO
Weei Jye Chay

ETFs linked to BTTC

Broad-market and Technology sector ETFs an investor holding Black Titan is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how BTTC fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze BTTC in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Black Titan?
Black Titan trades under the ticker BTTC on NASDAQ.
Which exchange is BTTC listed on?
BTTC is listed on NASDAQ.
What sector does Black Titan operate in?
Black Titan is classified in the Technology sector (Software - Application industry).
How can PortView help analyze BTTC in a portfolio?
PortView shows BTTC's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.